OptimizeRx Corp (OPRX) stock
OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/3030% below fair value
$7.34−1.53 (-17.25%)
Close on Nov 13, 2026Market cap $138.26MP/E 28.2Yield –
OptimizeRx total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
OptimizeRx's total debt was $12.73M at Sep 30, 2026. For fiscal 2025 it was $25.68M, down 21.8% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.68M | -21.8% |
| FY2024 | Dec 31, 2024 | $32.82M | -9.4% |
| FY2023 | Dec 31, 2023 | $36.23M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $12.73M | -54.7% |
| Q2 FY2026 | Jun 30, 2026 | $19.01M | -33.1% |
| Q1 FY2026 | Mar 31, 2026 | $23.34M | -28.2% |
| Q4 FY2025 | Dec 31, 2025 | $25.68M | -21.8% |
| Q3 FY2025 | Sep 30, 2025 | $28.10M | -20.3% |
| Q2 FY2025 | Jun 30, 2025 | $28.43M | -20.1% |
| Q1 FY2025 | Mar 31, 2025 | $32.49M | -9.5% |
| Q4 FY2024 | Dec 31, 2024 | $32.82M | -9.4% |
| Q3 FY2024 | Sep 30, 2024 | $35.28M | – |
| Q2 FY2024 | Jun 30, 2024 | $35.60M | – |
| Q1 FY2024 | Mar 31, 2024 | $35.91M | – |
| Q4 FY2023 | Dec 31, 2023 | $36.23M | – |
See a number that looks wrong?